- Home
- NXL
as 07-26-2024 4:00pm EST
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 14.7M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 762.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.25 - $4.05 | Next Earning Date: | 08-08-2024 |
| Revenue: | $158,860 | Revenue Growth: | -84.56% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Nexalin Technology Inc. News
NXL Breaking Stock News: Dive into NXL Ticker-Specific Updates for Smart Investing
ACCESSWIRE
10 hours ago
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
GlobeNewswire
8 days ago
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
MT Newswires
9 days ago
Nexalin Technology Says It Regains Nasdaq Compliance Following Stock Offering; Shares Fall
MT Newswires
25 days ago
Nexalin Technology Completes $5.3 Million Share Offering
GlobeNewswire
25 days ago
Nexalin Technology Announces Closing of $5.2 Million Public Offering
MT Newswires
a month ago
Top Midday Decliners
MT Newswires
a month ago
Top Premarket Decliners
GlobeNewswire
a month ago
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
Compare NXL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NXL Nexalin Technology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.